Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Single-dose Study of E6011 in Japanese Healthy Adult Subjects
jRCT2080221973Phase 1
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing E6011 single-dose IV with Placebo IV (2 arms).
02
Drugs
quetmolimab
Beyond the preview
Go deeper on jRCT2080221973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221973.